Steve kelsey

Company: Revolution Medicines

Job title: President

Seminars:

Targeting RAS(ON) Beyond KRAS G12C 9:30 am

Targeting RAS(ON) v first generation RAS(OFF) inhibitors Drugging RAS beyond G12C Targeted and rational combinationsRead more

day: Day Two